Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386697637> ?p ?o ?g. }
- W4386697637 abstract "Abstract Sorafenib therapy improves overall survival (OS) in patients with FLT3 internal tandem duplication (ITD) acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation. We explored the efficacy of sorafenib therapy in this population with different concomitant genetic patterns. In this multi-center, cohort study, we enrolled patients with FLT3-ITD AML undergoing allogenic hematopoietic cell transplantation. Patients with sorafenib maintenance post-transplantation for at least four weeks were allocated to the sorafenib group, and otherwise to the control group. Endpoints were OS, disease-free survival, and relapse for the whole cohort and OS for genetic pattern subgroups. Among 613 patients enrolled, 275 were in the sorafenib and 338 the control group. Median follow-up was 36.5 (interquartile range (IQR), 25.2–44.7) months post-transplantation. The 3-year OS post-transplantation was 79.6% (95% confidential interval (CI) 74.8%–84.6%) and 65.2% (95% CI 60.3%–70.6%) (Hazard ratio (HR) 0.50, 95% CI 0.37–0.69; P < 0.0001) in both groups. Sorafenib maintenance post-transplantation improved OS in the favorable (HR 0.33, 95% CI 0.14–0.77; P = 0.011) and adverse (HR 0.56, 95% CI 0.33–0.93; P = 0.026) ELN 2017 risk subgroups. Patients with mutated NPM1, DNMT3A, co-occurring NPM1/DNMT3A, “activated signaling” and “DNA methylation” genes benefited in OS from sorafenib maintenance, while those carrying CEBPA, “tumor suppressors” and “myeloid transcription factors” genes did not. Patients with FLT3-ITD high and FLT3-ITD low AML both benefited in OS from sorafenib maintenance. Our results identify the response of genetic patterns to sorafenib maintenance, providing new viewpoints for the optimal use of sorafenib in FLT3-ITD AML in the transplantation setting." @default.
- W4386697637 created "2023-09-14" @default.
- W4386697637 creator A5003282894 @default.
- W4386697637 creator A5003460402 @default.
- W4386697637 creator A5003657562 @default.
- W4386697637 creator A5010298865 @default.
- W4386697637 creator A5013146040 @default.
- W4386697637 creator A5022746945 @default.
- W4386697637 creator A5023708281 @default.
- W4386697637 creator A5023776809 @default.
- W4386697637 creator A5029592269 @default.
- W4386697637 creator A5030023423 @default.
- W4386697637 creator A5032457247 @default.
- W4386697637 creator A5035698719 @default.
- W4386697637 creator A5037458498 @default.
- W4386697637 creator A5041183580 @default.
- W4386697637 creator A5042449700 @default.
- W4386697637 creator A5046892926 @default.
- W4386697637 creator A5049131970 @default.
- W4386697637 creator A5049414098 @default.
- W4386697637 creator A5053447705 @default.
- W4386697637 creator A5055455306 @default.
- W4386697637 creator A5059032368 @default.
- W4386697637 creator A5061130250 @default.
- W4386697637 creator A5065034568 @default.
- W4386697637 creator A5069358812 @default.
- W4386697637 creator A5071773009 @default.
- W4386697637 creator A5074628027 @default.
- W4386697637 creator A5080036092 @default.
- W4386697637 creator A5080052819 @default.
- W4386697637 creator A5080152413 @default.
- W4386697637 date "2023-09-14" @default.
- W4386697637 modified "2023-10-16" @default.
- W4386697637 title "Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study" @default.
- W4386697637 cites W1491993932 @default.
- W4386697637 cites W1990924336 @default.
- W4386697637 cites W2024460356 @default.
- W4386697637 cites W2026241511 @default.
- W4386697637 cites W2030292335 @default.
- W4386697637 cites W2051293191 @default.
- W4386697637 cites W2052886921 @default.
- W4386697637 cites W2070824623 @default.
- W4386697637 cites W2112414163 @default.
- W4386697637 cites W2115707319 @default.
- W4386697637 cites W2325939231 @default.
- W4386697637 cites W2379365975 @default.
- W4386697637 cites W2412183643 @default.
- W4386697637 cites W2502940040 @default.
- W4386697637 cites W2559537906 @default.
- W4386697637 cites W2604772444 @default.
- W4386697637 cites W2715749014 @default.
- W4386697637 cites W2754160328 @default.
- W4386697637 cites W2789864883 @default.
- W4386697637 cites W2807088556 @default.
- W4386697637 cites W2902063722 @default.
- W4386697637 cites W2904378474 @default.
- W4386697637 cites W2904609036 @default.
- W4386697637 cites W2935980248 @default.
- W4386697637 cites W2938820794 @default.
- W4386697637 cites W2949363897 @default.
- W4386697637 cites W2961141193 @default.
- W4386697637 cites W2981883808 @default.
- W4386697637 cites W2994880414 @default.
- W4386697637 cites W3000653492 @default.
- W4386697637 cites W3014928753 @default.
- W4386697637 cites W3021443337 @default.
- W4386697637 cites W3033786947 @default.
- W4386697637 cites W3042846071 @default.
- W4386697637 cites W3047808971 @default.
- W4386697637 cites W3112827655 @default.
- W4386697637 cites W3130105428 @default.
- W4386697637 cites W3135647768 @default.
- W4386697637 cites W3184895242 @default.
- W4386697637 cites W3198585743 @default.
- W4386697637 cites W3208227917 @default.
- W4386697637 cites W4210773105 @default.
- W4386697637 cites W4226476218 @default.
- W4386697637 cites W4284884567 @default.
- W4386697637 cites W4289549935 @default.
- W4386697637 cites W4360949464 @default.
- W4386697637 cites W4375854036 @default.
- W4386697637 cites W4382934447 @default.
- W4386697637 doi "https://doi.org/10.1038/s41392-023-01614-1" @default.
- W4386697637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37704613" @default.
- W4386697637 hasPublicationYear "2023" @default.
- W4386697637 type Work @default.
- W4386697637 citedByCount "0" @default.
- W4386697637 crossrefType "journal-article" @default.
- W4386697637 hasAuthorship W4386697637A5003282894 @default.
- W4386697637 hasAuthorship W4386697637A5003460402 @default.
- W4386697637 hasAuthorship W4386697637A5003657562 @default.
- W4386697637 hasAuthorship W4386697637A5010298865 @default.
- W4386697637 hasAuthorship W4386697637A5013146040 @default.
- W4386697637 hasAuthorship W4386697637A5022746945 @default.
- W4386697637 hasAuthorship W4386697637A5023708281 @default.
- W4386697637 hasAuthorship W4386697637A5023776809 @default.
- W4386697637 hasAuthorship W4386697637A5029592269 @default.
- W4386697637 hasAuthorship W4386697637A5030023423 @default.
- W4386697637 hasAuthorship W4386697637A5032457247 @default.
- W4386697637 hasAuthorship W4386697637A5035698719 @default.